Guosong J. Jiang

Union Hospital
Wuhan, 430022, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 65 publications

Recent advances in the design and development of small molecules targeting the TLR4 signaling pathway.

Recent advances in the design and development of small molecules targeting the TLR4 signaling pathway.

Journal: Future medicinal chemistry
Published: March 24, 2026

Inhibition of TGM2 enhances cisplatin sensitivity in MSH2-deficient bladder cancer.

Inhibition of TGM2 enhances cisplatin sensitivity in MSH2-deficient bladder cancer.

Journal: Cell death discovery
Published: December 15, 2025

MoN/Au/cTAT Boosted Sonochemotherapy Post-Intravesical Instillation in Bladder Cancer.

MoN/Au/cTAT Boosted Sonochemotherapy Post-Intravesical Instillation in Bladder Cancer.

Journal: Small (Weinheim an der Bergstrasse, Germany)
Published: September 12, 2025

CUL5 E3 ubiquitin ligase regulates the evasion of bladder cancer cells to CD8+ T cell-mediated killing by inhibiting autophagy.

CUL5 E3 ubiquitin ligase regulates the evasion of bladder cancer cells to CD8+ T cell-mediated killing by inhibiting autophagy.

Journal: PLoS biology
Published: April 09, 2025

Exploring a multi-path U-net with probability distribution attention and cascade dilated convolution for precise retinal vessel segmentation in fundus images.

Exploring a multi-path U-net with probability distribution attention and cascade dilated convolution for precise retinal vessel segmentation in fundus images.

Journal: Scientific reports
Published: October 25, 2024

Targeting COPA to Enhance Erdafitinib Sensitivity in FGFR-Altered Bladder Cancer.

Targeting COPA to Enhance Erdafitinib Sensitivity in FGFR-Altered Bladder Cancer.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: October 18, 2024

A Genome-Wide Synthetic Lethal Screen Identifies Spermidine Synthase as a Target to Enhance Erdafitinib Efficacy in FGFR-Mutant Bladder Cancer.

A Genome-Wide Synthetic Lethal Screen Identifies Spermidine Synthase as a Target to Enhance Erdafitinib Efficacy in FGFR-Mutant Bladder Cancer.

Journal: Cancer research
Published: September 09, 2024

XIAP promotes metastasis of bladder cancer cells by ubiquitylating YTHDC1.

XIAP promotes metastasis of bladder cancer cells by ubiquitylating YTHDC1.

Journal: Cell death & disease
Published: June 06, 2024

Surgical Strategies and Perioperative Outcomes of Robot-Assisted Vena Cava Reconstruction.

Surgical Strategies and Perioperative Outcomes of Robot-Assisted Vena Cava Reconstruction.

Journal: The international journal of medical robotics + computer assisted surgery : MRCAS
Published: March 26, 2024

CLIC3 interacts with NAT10 to inhibit N4-acetylcytidine modification of p21 mRNA and promote bladder cancer progression.

CLIC3 interacts with NAT10 to inhibit N4-acetylcytidine modification of p21 mRNA and promote bladder cancer progression.

Journal: Cell death & disease
Published: August 06, 2023

ARID1A Inactivation Increases Expression of circ0008399 and Promotes Cisplatin Resistance in Bladder Cancer.

ARID1A Inactivation Increases Expression of circ0008399 and Promotes Cisplatin Resistance in Bladder Cancer.

Journal: Current medical science
Published: January 02, 2023

Correction: CircPTPRA blocks the recognition of RNA N6-methyladenosine through interacting with IGF2BP1 to suppress bladder cancer progression.

Correction: CircPTPRA blocks the recognition of RNA N6-methyladenosine through interacting with IGF2BP1 to suppress bladder cancer progression.

Journal: Molecular cancer
Published: November 01, 2022
Showing 1-12 of 65

Last Updated: 09/26/2026